PregLem

PharmaceuticalsSeries BGeneva, Switzerlandpreglem.com

Latest round

Series B

Last raised

Oct 2010

Total raised

$69M

Investors

4

About PregLem

PregLem SA, founded in 2006, is headquartered in Geneva, Switzerland. The company specializes in biopharmaceutical solutions for women's health. In October 2010, PregLem was acquired by Gedeon Richter Plc for CHF 150 million, with potential milestone payments of up to CHF 295 million.PregLem SA offers a range of innovative biopharmaceutical solutions tailored to the needs of healthcare providers and patients in the women's health sector. Their products aim to enhance reproductive health management, with particular focus on therapies that support fertility and related conditions.PregLem SA's revenue model centers around B2B transactions and direct-to-consumer sales, primarily through subscription-based services. Clients benefit from ongoing access to their biopharmaceutical products, ensuring they remain updated with the latest treatment options. The company also engages in bulk sales to wholesalers, allowing for wider market reach.PregLem SA aims to expand its product portfolio with new treatments in women's health, targeting release by 2011. The recent acquisition by Gedeon Richter Plc will support these initiatives, with the initial cash consideration of CHF 150 million and milestone payments facilitating further research and development. The company plans to explore new markets, particularly in Asia, to broaden its reach and impact in the women's health sector.

Who invested in PregLem

4 investors across 4 rounds

See all investors in PregLem

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 5, 2010

    Amount

    $10M

    Investors

    Locked

  2. Series B

    Dec 14, 2007

    Amount

    $32M

    Investors

    Locked

  3. Series A

    Jun 27, 2007

    Amount

    $26M

    Investors

    Locked

  4. Seed

    Sep 1, 2006

    Amount

    $0.3M

    Investors

    Locked

Questions about PregLem

Who invested in PregLem?

PregLem has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PregLem raised?

PregLem has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did PregLem last raise money?

PregLem's most recent round on record is a Series B, in Oct 2010.

What does PregLem do?

PregLem SA, founded in 2006, is headquartered in Geneva, Switzerland.

Where is PregLem headquartered?

PregLem is headquartered in Geneva, Switzerland.

Which VCs invest in companies like PregLem?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at PregLem's stage. Their profiles are linked below.

Raising like PregLem? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.